Meanwhile, inhibition of YAP or BCL-xL (TW37, ABT-263) synergistically increased the cytotoxic effect of RAF and MEK inhibitors on NSCLC cells [91]. The gene discussed is BCL2L1; the disease is non-small cell lung carcinoma.